Creating Impactful Deals Across Healthcare & Life science

2025

Strategic Divestitures for Bayer Pharma

Link

2025

Raised pre-ipo round for boat building company

Link

2022

Divested AFDIL's portfolio of brands to Lupin Limited

Link

2025

Facilitating Landmark Innovation Investments: Alveolus Bio and Shilpa Pharma

Link

2025

Strategic Brand Acquisitions: CORONA Remedies and Bayer Pharma

Link

Strategic brand divestment for Galderma

Learn more

Strategic Investment for Generic Partners (Australia) from Strides Pharma

Learn more

Advised Natural Endotech for its entry into Indian market with Patented Women-Care Product

Learn more

GCViB Advises on Licensing of Entra Health Systems’ Medical Device into the Indian Market

Learn more

GCViB Facilitates the India Launch of Unicity

Learn more

2025

GCV IB Advises on Zeus Hygia’s Series A Funding of $2.5 million from NABVENTURES

Learn more

    GCViB is a boutique investment bank Specializing in healthcare & life science sector. We deliver transaction advisory service to companies in biotechnology, pharmaceuticals, healthcare, and MedTech.

    Read More
    Linkedin

    Quick links

    About Us
    Services
    Transactions
    Contact Us
    Privacy Policy

    Contact Us

    501, Windfall, Sahar Plaza Complex, Andheri- Kurla Road, Andheri(East), Mumbai-400059

    +91 -22-4254-7000

    investmentbanking@gcvlife.in

    © 2025 GCViB | Boutique Healthcare & Life Sciences Investment Bank